vs
Side-by-side financial comparison of BRC Inc. (BRCC) and Cytek Biosciences, Inc. (CTKB). Click either name above to swap in a different company.
BRC Inc. is the larger business by last-quarter revenue ($112.7M vs $62.1M, roughly 1.8× Cytek Biosciences, Inc.). BRC Inc. runs the higher net margin — -2.8% vs -70.9%, a 68.1% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs 6.5%). Cytek Biosciences, Inc. produced more free cash flow last quarter ($-1.8M vs $-9.4M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 7.0%).
BRC Inc., operating under the Black Rifle Coffee brand, is a U.S.-headquartered premium coffee and lifestyle brand. It sells roasted coffee beans, ready-to-drink coffee products, branded apparel, and outdoor gear, targeting primarily veteran, first responder, and outdoor enthusiast consumer segments across North America, via both e-commerce and physical retail channels.
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
BRCC vs CTKB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $112.7M | $62.1M |
| Net Profit | $-3.2M | $-44.1M |
| Gross Margin | 32.1% | 52.9% |
| Operating Margin | -6.3% | -9.0% |
| Net Margin | -2.8% | -70.9% |
| Revenue YoY | 6.5% | 8.1% |
| Net Profit YoY | -29.3% | -557.1% |
| EPS (diluted) | $-0.02 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $112.7M | $62.1M | ||
| Q3 25 | $100.7M | $52.3M | ||
| Q2 25 | $94.8M | $45.6M | ||
| Q1 25 | $90.0M | $41.5M | ||
| Q4 24 | $105.9M | $57.5M | ||
| Q3 24 | $98.2M | $51.5M | ||
| Q2 24 | $89.0M | $46.6M | ||
| Q1 24 | $98.4M | $44.9M |
| Q4 25 | $-3.2M | $-44.1M | ||
| Q3 25 | $-486.0K | $-5.5M | ||
| Q2 25 | $-5.3M | $-5.6M | ||
| Q1 25 | $-2.9M | $-11.4M | ||
| Q4 24 | $-2.5M | $9.6M | ||
| Q3 24 | $-535.0K | $941.0K | ||
| Q2 24 | $-482.0K | $-10.4M | ||
| Q1 24 | $548.0K | $-6.2M |
| Q4 25 | 32.1% | 52.9% | ||
| Q3 25 | 36.9% | 52.7% | ||
| Q2 25 | 33.9% | 52.3% | ||
| Q1 25 | 36.1% | 48.6% | ||
| Q4 24 | 38.1% | 58.5% | ||
| Q3 24 | 42.1% | 56.3% | ||
| Q2 24 | 41.9% | 54.6% | ||
| Q1 24 | 42.9% | 51.3% |
| Q4 25 | -6.3% | -9.0% | ||
| Q3 25 | 0.5% | -17.6% | ||
| Q2 25 | -13.3% | -23.3% | ||
| Q1 25 | -6.0% | -36.1% | ||
| Q4 24 | -2.1% | 5.2% | ||
| Q3 24 | 1.1% | -8.2% | ||
| Q2 24 | 1.1% | -18.3% | ||
| Q1 24 | 4.0% | -23.9% |
| Q4 25 | -2.8% | -70.9% | ||
| Q3 25 | -0.5% | -10.5% | ||
| Q2 25 | -5.6% | -12.2% | ||
| Q1 25 | -3.2% | -27.5% | ||
| Q4 24 | -2.3% | 16.8% | ||
| Q3 24 | -0.5% | 1.8% | ||
| Q2 24 | -0.5% | -22.4% | ||
| Q1 24 | 0.6% | -13.8% |
| Q4 25 | $-0.02 | — | ||
| Q3 25 | $0.00 | — | ||
| Q2 25 | $-0.07 | — | ||
| Q1 25 | $-0.04 | — | ||
| Q4 24 | $-0.03 | — | ||
| Q3 24 | $-0.01 | — | ||
| Q2 24 | $-0.01 | — | ||
| Q1 24 | $0.01 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.3M | $90.9M |
| Total DebtLower is stronger | $34.7M | — |
| Stockholders' EquityBook value | $45.7M | $341.7M |
| Total Assets | $209.2M | $461.5M |
| Debt / EquityLower = less leverage | 0.76× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.3M | $90.9M | ||
| Q3 25 | $9.5M | $93.3M | ||
| Q2 25 | $4.3M | $75.5M | ||
| Q1 25 | $3.9M | $95.3M | ||
| Q4 24 | $6.8M | $98.7M | ||
| Q3 24 | $7.3M | $162.3M | ||
| Q2 24 | $9.6M | $177.9M | ||
| Q1 24 | $4.0M | $168.8M |
| Q4 25 | $34.7M | — | ||
| Q3 25 | $35.0M | — | ||
| Q2 25 | $72.7M | — | ||
| Q1 25 | $68.8M | — | ||
| Q4 24 | $65.1M | — | ||
| Q3 24 | $64.9M | — | ||
| Q2 24 | $66.5M | — | ||
| Q1 24 | $61.5M | — |
| Q4 25 | $45.7M | $341.7M | ||
| Q3 25 | $48.0M | $378.6M | ||
| Q2 25 | $10.1M | $377.6M | ||
| Q1 25 | $11.2M | $379.6M | ||
| Q4 24 | $13.2M | $395.7M | ||
| Q3 24 | $14.5M | $385.5M | ||
| Q2 24 | $14.9M | $389.1M | ||
| Q1 24 | $14.6M | $392.6M |
| Q4 25 | $209.2M | $461.5M | ||
| Q3 25 | $222.4M | $494.9M | ||
| Q2 25 | $225.3M | $493.3M | ||
| Q1 25 | $222.9M | $482.6M | ||
| Q4 24 | $227.4M | $499.5M | ||
| Q3 24 | $233.7M | $491.2M | ||
| Q2 24 | $229.9M | $483.7M | ||
| Q1 24 | $227.2M | $492.1M |
| Q4 25 | 0.76× | — | ||
| Q3 25 | 0.73× | — | ||
| Q2 25 | 7.19× | — | ||
| Q1 25 | 6.15× | — | ||
| Q4 24 | 4.94× | — | ||
| Q3 24 | 4.47× | — | ||
| Q2 24 | 4.46× | — | ||
| Q1 24 | 4.21× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-8.7M | $-771.0K |
| Free Cash FlowOCF − Capex | $-9.4M | $-1.8M |
| FCF MarginFCF / Revenue | -8.3% | -2.9% |
| Capex IntensityCapex / Revenue | 0.6% | 1.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-13.5M | $-8.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-8.7M | $-771.0K | ||
| Q3 25 | $6.4M | $-3.9M | ||
| Q2 25 | $-3.3M | $108.0K | ||
| Q1 25 | $-4.1M | $-125.0K | ||
| Q4 24 | $2.2M | $2.0M | ||
| Q3 24 | $1.9M | $13.2M | ||
| Q2 24 | $2.3M | $6.2M | ||
| Q1 24 | $4.9M | $4.0M |
| Q4 25 | $-9.4M | $-1.8M | ||
| Q3 25 | $5.6M | $-4.6M | ||
| Q2 25 | $-4.3M | $-1.5M | ||
| Q1 25 | $-5.3M | $-974.0K | ||
| Q4 24 | $504.0K | $1.1M | ||
| Q3 24 | $-205.0K | $12.2M | ||
| Q2 24 | $147.0K | $5.2M | ||
| Q1 24 | $2.2M | $3.4M |
| Q4 25 | -8.3% | -2.9% | ||
| Q3 25 | 5.5% | -8.7% | ||
| Q2 25 | -4.5% | -3.2% | ||
| Q1 25 | -5.9% | -2.3% | ||
| Q4 24 | 0.5% | 1.9% | ||
| Q3 24 | -0.2% | 23.7% | ||
| Q2 24 | 0.2% | 11.0% | ||
| Q1 24 | 2.2% | 7.6% |
| Q4 25 | 0.6% | 1.6% | ||
| Q3 25 | 0.8% | 1.3% | ||
| Q2 25 | 1.0% | 3.5% | ||
| Q1 25 | 1.3% | 2.0% | ||
| Q4 24 | 1.6% | 1.6% | ||
| Q3 24 | 2.2% | 2.0% | ||
| Q2 24 | 2.4% | 2.3% | ||
| Q1 24 | 2.8% | 1.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.21× | ||
| Q3 24 | — | 14.05× | ||
| Q2 24 | — | — | ||
| Q1 24 | 8.97× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BRCC
| Sales Channel Through Intermediary | $72.9M | 65% |
| Sales Channel Directly To Consumer | $34.4M | 31% |
| Outpost | $5.4M | 5% |
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
